Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Standard Anti-Vomiting Medicine During the First Course of Chemotherapy
This study has been completed.
Study NCT00729677 Information provided by National Cancer Institute (NCI)
First Received: August 6, 2008 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Nausea and Vomiting
Additional conditions recognized in this trial
Colorectal Neoplasms
Nausea
Vomiting
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
fluorouracil
leucovorin calcium
oxaliplatin
questionnaire administration
assessment of therapy complications
nausea and vomiting therapy
quality-of-life assessment
Additional drug interventions recognized in this trial
Leucovorin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Beth Israel Medical Center
Back to top of Main Content
